These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1283128)

  • 21. Long-term strategies for the treatment of Refsum's disease using therapeutic apheresis.
    Zolotov D; Wagner S; Kalb K; Bunia J; Heibges A; Klingel R
    J Clin Apher; 2012; 27(2):99-105. PubMed ID: 22267052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disorders related to the metabolism of phytanic acid.
    Stokke O; Skjeldal OH; Høie K
    Scand J Clin Lab Invest Suppl; 1986; 184():3-10. PubMed ID: 2438746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heredopathia atactica polyneuritiformis (refsum's disease) treated by diet and plasma-exchange.
    Gibberd FB; Billimoria JD; Page NG; Retsas S
    Lancet; 1979 Mar; 1(8116):575-8. PubMed ID: 85164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Refsum syndrome, heredopathia atactica polyneuritiformis in the view of the otolaryngologist (author's transl)].
    Feldmann H
    Laryngol Rhinol Otol (Stuttg); 1981 May; 60(5):235-40. PubMed ID: 6164893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and biochemical heterogeneity in conditions with phytanic acid accumulation.
    Skjeldal OH; Stokke O; Refsum S; Norseth J; Petit H
    J Neurol Sci; 1987 Jan; 77(1):87-96. PubMed ID: 2433405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma exchange for Refsum's disease.
    Gibberd FB
    Transfus Sci; 1993 Jan; 14(1):23-6. PubMed ID: 10150979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Refsum's disease and metabolism of phytanic acid.
    Stokke O; Refsum S
    Lancet; 1982 Apr; 1(8277):906-7. PubMed ID: 6175864
    [No Abstract]   [Full Text] [Related]  

  • 28. Patterns of Refsum's disease. Phytanic acid oxidase deficiency.
    Poulos A; Pollard AC; Mitchell JD; Wise G; Mortimer G
    Arch Dis Child; 1984 Mar; 59(3):222-9. PubMed ID: 6201142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heredopathia atactica polyneuritiformis: Refsum's disease.
    Gibberd FB; Billimoria JD; Goldman JM; Clemens ME; Evans R; Whitelaw MN; Retsas S; Sherratt RM
    Acta Neurol Scand; 1985 Jul; 72(1):1-17. PubMed ID: 2413704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2,6-Dimethyloctanedioic acid--a metabolite of phytanic acid in Refsum's disease.
    Greter J; Lindstedt S; Steen G
    Clin Chem; 1983 Mar; 29(3):434-7. PubMed ID: 6186413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening of patients with retinitis pigmentosa for heredopathia atactica polyneuritiformis (Refsum's disease).
    Goldman JM; Clemens ME; Gibberd FB; Billimoria JD
    Br Med J (Clin Res Ed); 1985 Apr; 290(6475):1109-10. PubMed ID: 2580589
    [No Abstract]   [Full Text] [Related]  

  • 32. Refsum's disease may mimic familial Guillain Barre syndrome.
    Verny C; Prundean A; Nicolas G; Pautot V; Maugin D; Levade T; Bonneau D; Dubas F
    Neuromuscul Disord; 2006 Nov; 16(11):805-8. PubMed ID: 16934464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on the phytol metabolism in lipoidosis heredopathia atactica polyneuritiformis (Refsum's syndrome). The transformation of 3H-phytol into the 3,7,11,15-tetramethylhexadecanoic acid (phytanic acid) of the plasma lipoid fractions].
    Kahlke W; Wagener H; Dieckmann H
    Klin Wochenschr; 1965 Dec; 43(24):1345-7. PubMed ID: 4163289
    [No Abstract]   [Full Text] [Related]  

  • 34. Metabolism of phytanic acid in Refsum's disease.
    Billimoria JD; Clemens ME; Gibberd FB; Whitelaw MN
    Lancet; 1982 Jan; 1(8265):194-6. PubMed ID: 6172683
    [No Abstract]   [Full Text] [Related]  

  • 35. Mild retinal changes in a 47-year-old patient with phytanic acid storage disease.
    Yamamoto S; Onozu H; Yamada N; Hayasaka S; Watanabe A
    Ophthalmologica; 1995; 209(5):251-5. PubMed ID: 8570147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phytanic acid oxidase activity in cultured skin fibroblasts. Diagnostic usefulness and limitations.
    Skjeldal OH; Stokke O; Norseth J; Lie SO
    Scand J Clin Lab Invest; 1986 May; 46(3):283-7. PubMed ID: 2424078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infantile Refsum's disease: a peroxisomal storage disorder?
    Manson JI; Pollard AC; Poulos A; Carter RF
    Clin Exp Neurol; 1985; 21():283-7. PubMed ID: 2436838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisomes, Refsum's disease and the alpha- and omega-oxidation of phytanic acid.
    Wanders RJ; Komen JC
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):865-9. PubMed ID: 17956234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo study of phytanic acid alpha-oxidation in classic Refsum's disease and chondrodysplasia punctata.
    ten Brink HJ; Schor DS; Kok RM; Stellaard F; Kneer J; Poll-The BT; Saudubray JM; Jakobs C
    Pediatr Res; 1992 Nov; 32(5):566-70. PubMed ID: 1282700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phytyl fatty acid esters in vegetables pose a risk for patients suffering from Refsum's disease.
    Krauß S; Michaelis L; Vetter W
    PLoS One; 2017; 12(11):e0188035. PubMed ID: 29131855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.